Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

NGM Biopharmaceuticals (NGM) News Today

NGM Biopharmaceuticals logo
Psychedelic Stock Deep Dive: Atai Life Sciences
Sino Biopharmaceutical Ltd 01177
Merck to buy eye drug developer for $1.3B
NGM Bio Announces Closing of Tender Offer
NGM Biopharmaceuticals, Inc. stock logo
NGM Biopharmaceuticals (NASDAQ:NGM) Lowered to "Market Perform" at Raymond James
Raymond James cut NGM Biopharmaceuticals from an "outperform" rating to a "market perform" rating in a research note on Tuesday.
NGM Biopharmaceuticals, Inc. stock logo
NGM Biopharmaceuticals (NASDAQ:NGM) Downgraded to Neutral at B. Riley
B. Riley lowered NGM Biopharmaceuticals from a "buy" rating to a "neutral" rating in a research note on Wednesday.
NGM Biopharmaceuticals, Inc. stock logo
TD Cowen Downgrades NGM Biopharmaceuticals (NASDAQ:NGM) to Market Perform
TD Cowen lowered NGM Biopharmaceuticals from an "outperform" rating to a "market perform" rating in a research note on Wednesday.
NGM Biopharmaceuticals, Inc. stock logo
NGM Biopharmaceuticals (NASDAQ:NGM) Downgraded by Citigroup
Citigroup cut NGM Biopharmaceuticals from a "buy" rating to a "neutral" rating in a research note on Tuesday.
NGM Bio To Be Acquired By Affiliates Of The Column Group, LP
NGM to go private through deal with investment firm
NGM Biopharmaceuticals, Inc. stock logo
NGM Biopharmaceuticals (NGM) Scheduled to Post Earnings on Monday
NGM Biopharmaceuticals (NASDAQ:NGM) will be releasing earnings on Monday, February 26, Yahoo Finance reports.
NGM Biopharmaceuticals, Inc. stock logo
NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Sees Significant Increase in Short Interest
NGM Biopharmaceuticals, Inc. (NASDAQ:NGM - Get Free Report) was the target of a significant increase in short interest in January. As of January 31st, there was short interest totalling 1,680,000 shares, an increase of 9.1% from the January 15th total of 1,540,000 shares. Based on an average daily volume of 961,800 shares, the short-interest ratio is currently 1.7 days. Currently, 4.1% of the company's stock are sold short.
NGM Biopharmaceuticals, Inc. (NGM)
NGM Biopharmaceuticals, Inc. stock logo
NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Short Interest Down 34.4% in December
NGM Biopharmaceuticals, Inc. (NASDAQ:NGM - Get Free Report) was the target of a significant decrease in short interest during the month of December. As of December 31st, there was short interest totalling 1,640,000 shares, a decrease of 34.4% from the December 15th total of 2,500,000 shares. Based on an average daily trading volume, of 993,600 shares, the short-interest ratio is currently 1.7 days. Currently, 4.0% of the shares of the company are short sold.
Get NGM Biopharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for NGM and its competitors with MarketBeat's FREE daily newsletter.

2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]

NGM Media Mentions By Week

NGM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NGM
News Sentiment

0.00

0.59

Average
Medical
News Sentiment

NGM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NGM Articles
This Week

2

1

NGM Articles
Average Week

Get NGM Biopharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for NGM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:NGM) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners